Alnylam Pharma (ALNY) Tops Q1 EPS by 35c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $251.65 --0%
EPS Growth %: -39.0%
Financial Fact:
Net loss: -90.13M
Today's EPS Names:
NEOV, MANU, CTAS, More
EPS Growth %: -39.0%
Financial Fact:
Net loss: -90.13M
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q1 EPS of ($1.49), $0.35 better than the analyst estimate of ($1.84). Revenue for the quarter came in at $213.26 million versus the consensus estimate of $243.02 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
